233 related articles for article (PubMed ID: 16522732)
21. Evaluation of tumor necrosis factor alpha production in ex vivo short term cultured whole blood from women with polycystic ovary syndrome.
Araya AV; Aguirre A; Romero C; Miranda C; Molina MC; Ferreira A
Eur Cytokine Netw; 2002; 13(4):419-24. PubMed ID: 12517726
[TBL] [Abstract][Full Text] [Related]
22. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
23. Is the polycystic ovary syndrome associated with chronic inflammation per se?
Olszanecka-Glinianowicz M; Banaś M; Zahorska-Markiewicz B; Janowska J; Kocełak P; Madej P; Klimek K
Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):197-202. PubMed ID: 17224231
[TBL] [Abstract][Full Text] [Related]
24. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
25. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation.
Malin SK; Kirwan JP; Sia CL; González F
Am J Physiol Endocrinol Metab; 2015 May; 308(9):E770-7. PubMed ID: 25714674
[TBL] [Abstract][Full Text] [Related]
27. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
González F; Rote NS; Minium J; Kirwan JP
J Clin Endocrinol Metab; 2006 Jan; 91(1):336-40. PubMed ID: 16249279
[TBL] [Abstract][Full Text] [Related]
28. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
Słopień R; Lewandowski K; Kolacz E; Zawilska K; Warenik-Szymankiewicz A
Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome.
Savastano S; Orio F; Palomba S; Cascella T; Manguso F; Lupoli GA; Formisano P; Lombardi G; Colao A; Beguinot F; Valentino R
Clin Endocrinol (Oxf); 2007 Oct; 67(4):557-62. PubMed ID: 17590172
[TBL] [Abstract][Full Text] [Related]
30. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
31. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
32. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
[TBL] [Abstract][Full Text] [Related]
33. Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment.
Jakubowska J; Bohdanowicz-Pawlak A; Milewicz A; Szymczak J; Bednarek-Tupikowska G; Demissie M
Gynecol Endocrinol; 2008 Jul; 24(7):378-84. PubMed ID: 18645710
[TBL] [Abstract][Full Text] [Related]
34. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome.
Bik W; Baranowska-Bik A; Wolinska-Witort E; Chmielowska M; Martynska L; Baranowska B
Gynecol Endocrinol; 2007 Jun; 23(6):325-31. PubMed ID: 17616856
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome.
Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S233-7. PubMed ID: 17606307
[TBL] [Abstract][Full Text] [Related]
36. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
[TBL] [Abstract][Full Text] [Related]
37. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance.
Janowska J; Zahorska-Markiewicz B; Olszanecka-Glinianowicz M
Metabolism; 2006 Nov; 55(11):1495-9. PubMed ID: 17046552
[TBL] [Abstract][Full Text] [Related]
38. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
39. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
Takeuchi T; Tsutsumi O; Taketani Y
Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711
[TBL] [Abstract][Full Text] [Related]
40. The altered mononuclear cell-derived cytokine response to glucose ingestion is not regulated by excess adiposity in polycystic ovary syndrome.
González F; Sia CL; Shepard MK; Rote NS; Minium J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2244-51. PubMed ID: 25078146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
